Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab

Fig. 2

Relationship between Hb levels and clinical efficacy outcomes: PtGA and pain VAS over time. Slicefit plots of PtGA (MM) and pain VAS (MM) (Y-axis) against hemoglobin (g/L) (X-axis) by a visit from baseline to week 24. Each panel in the regression model shows the relationship between an outcome and Hb level at a given point in time, stratified by treatment. The lines, with shading, depict the treatment-specific regression coefficient (i.e., slope) and 95% CI associated with the linear regression in which Hb is the independent variable and the outcome is the dependent variable. Hb, hemoglobin; pain VAS, pain visual analog scale; PtGA, Patient Global Assessment; q2w, every 2 weeks

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us